TNDM:NASDAQ
Tandem Diabetes Care Inc
US$ 16,31
arrow_downward
-1,57%(-0,26) 1D
US$ 16,31
0,00% (0,00)
bedtimeNa sluitingstijd
Gesloten: 30 sep, 16:00:00 GMT-4 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TNDM genereren…
Openen
US$ 16,63
Hoog
US$ 16,68
Laag
US$ 16,00
Beursw.
1,13 mld.
Gem. vol.
1,90 mln.
Volume
2,20 mln.
52 wk hoog
US$ 29,65
52 wk laag
US$ 12,07
WPA
US$ -0,93
Bèta
1,55
Uitstaande aandelen
69,58 mln.
Aantal medewerkers
2K
Openen
US$ 16,63
Hoog
US$ 16,68
Laag
US$ 16,00
Beursw.
1,13 mld.
Gem. vol.
1,90 mln.
Volume
2,20 mln.
52 wk hoog
US$ 29,65
52 wk laag
US$ 12,07
WPA
US$ -0,93
Bèta
1,55
Uitstaande aandelen
69,58 mln.
Aantal medewerkers
2K
Nieuwsartikelen
Van webbronnen en nieuwspartners
GuruFocus
·
8 uur geleden
TNDM Maintained by Citigroup -- Price Target Lowered to $20
Simply Wall Street
·
1 dag geleden
How International Pump Launch Has Changed Its Investment Story At Tandem Diabetes Care (TNDM)
Profiel
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Over Tandem Diabetes Care Inc